Metabolic engineering for industrial applications plays a vital role in redesigning cellular pathways to optimize the production of valuable biochemicals, fuels, and pharmaceuticals. Through precise genetic modifications, synthetic regulatory circuits, and pathway balancing, scientists are enhancing microbial and cellular hosts such as E. coli, Saccharomyces cerevisiae, and cyanobacteria to serve as efficient biocatalysts. The integration of CRISPR-based tools, systems biology, and high-throughput screening has further accelerated strain improvement and yield optimization. Metabolic Engineering for Industrial Applications also focuses on minimizing by-products, improving substrate utilization, and enabling the use of inexpensive feedstocks like lignocellulose and waste glycerol. With increasing demand for bio-based manufacturing and climate-neutral processes, this field contributes directly to sustainable industrial biotechnology, supporting the scalable and cost-effective production of green alternatives across chemical, energy, and materials sectors.
Title : Targeting noncanonical epitopes in anti-cancer immunotherapy
Michele Mishto, Francis Crick Institute, United Kingdom
Title : Effect of maltogenic amylase, high-performance maltogenic amylase enzymes, and Bacillus coagulans probiotic bacteria on the shelf life and other properties of baked bread and tortilla
Assad Alammar, Specialty Enzymes and Probiotics, United States
Title : Solving the challenges of engineering an ultra-long acting insulin
Tina Moller Tagmose, Novo Nordisk A/S, Denmark
Title : The lines of antigen-antibody interactions in vitro and their significance for sensitive and specific antigen and antibody assays, including hybrid ELISAs, and for the possibility of more efficacious vaccines
Viggo Bitsch, Retired, Independent Researcher, Denmark
Title : Lignocellulosic biomass to biofuels and biochemicals: Microbial innovations for a sustainable future
Gunjan Mukherjee, Chandigarh University, India
Title : Eliminating implant infection: 30,000 nanotextured implants in humans with no failure
Thomas J Webster, Brown University, United States